[An Analysis of Basic Clinical Data on Hemorrhagic Stroke Patients Using the Korean Hemorrhagic Stroke Registry]

Won Joo Lee1, Soon Chan Kwon1,2, Dongkeun Hyun3

  • 1울산대학교병원 울산권역심뇌혈관질환센터.

PubMed

Stroke is a major cause of death and disability in Korea and given its aging population, stroke incidence cases are expected to continue to increase. In particular, hemorrhagic stroke is a highly severe type of strokes with poor prognosis. Therefore, it is necessary to build the multi-center registry system to accumulate data on clinical and epidemiological characteristics of various hemorrhagic stroke patients and based on the accumulated data to do researches on it. This study made into database the clinical data on 457 hemorrhagic stroke patients of three Korean university hospitals (Regional Cardiocerebrovascular Centers) included in the Korean Hemorrhagic Stroke Registry from September 1, 2021 to July 31, 2022 and analyzed the data. The mean age of patients in the registry was 62.8 years old, with males being 51.4%. Among them, the largest proportion of hemorrhagic stroke was taken up by intracerebral hemorrhage (68.9%), followed by subarachnoid hemorrhage (26.1%) and intraventricular hemorrhage (5.0%). 61.7% of patients arrived within 3 hours of onset, and 81.4% of patients were carried to hospital by ambulance. Arriving at hospital, 49.2% of patients were under stupor or worse. The most prevalent risk factor for hemorrhagic stroke was high blood pressure (50.5%), followed by alcohol (37.6%) and smoking (24.3%). The mean rate of expired at hospital was 13.6%, with that of subarachnoid hemorrhage being the highest (18.5%). This study expects that there will be further long-term follow-up studies in the future that will contribute to creating the guidelines for hemorrhagic stroke and establishing national public health policies.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...